Identity
- Security key
- 12352
- Ticker
- BCTX
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2023-09-05
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- BCTX
Detail
Enriched 2026-08-14 20:47
- Market cap
- $29,666,273.67
- Shares outstanding (class)
- 8,699,787
- Shares outstanding (weighted)
- 8,699,787
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 4
- Location
- WEST VANCOUVER, A1
- Homepage
- https://www.briacell.com
- Description
BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.
Market cap and share counts drift.